CompanyDeals

Phil Rivers Tech Raises RMB 100 Million for Computational Medicine Push

CompanyDrug

Gan & Lee Pharmaceuticals Doses First Patient in GZR101 Phase I Study

CompanyDrug

Fosun Pharma’s FS-1502 Gets NMPA Approval for Gastric Cancer Study

CompanyDrug

GeneScience’s Somatropin Wins NMPA Approval for Prader-Willi Syndrome

CompanyDrug

Inmagene and HutchMed Dose First Patient in IMG-007 Global Phase I Study

CompanyDeals

ClinChoice Raises USD 150M in Funding Led by Legend Capital for Expansion

Drug

InnoCare Pharma’s BCL2 Inhibitor ICP-248 Accepted for NMPA Review

CompanyDeals

Shenzhen TargetRx Raises Hundreds of Millions in Series B Financing for Drug Development

Drug

Ascletis Pharma Files IND Application for ASC10 with US FDA

CompanyDrug

MabPharm’s CMAB017 Receives NMPA Approval for Clinical Study in Solid Tumors

CompanyDeals

Zhejiang Medicine’s NovoCodex Subsidiary Receives RMB 402M Investment

CompanyDeals

Medicilon Biomedical Plans RMB 2.16B Private Placement for R&D Expansion